Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01029106
Other study ID # TVTSecur
Secondary ID 047-2009
Status Terminated
Phase N/A
First received October 19, 2009
Last updated July 27, 2011
Start date September 2009

Study information

Verified date July 2011
Source Sunnybrook Health Sciences Centre
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Observational

Clinical Trial Summary

This is a prospective, non-randomized, observational, multicentre (5 sites) study in which subjects that have surgically-correctable Stress Urinary Incontinence undergo a TVT SECUR operative procedure.

The study will collect preoperative urologic testing, medical history, and subject quality of life patient questionnaires, Intraoperative procedural data will be collected.

Postoperative complications, urologic, testing, and subject questionnaires will be collected at intervals up to 24 months. The anatomic position of the device will be characterize by transvaginal ultrasound testing.

To determine the rate and/or improvement rate of patients who have received the Gynecare Secur device after 12 months and after 24 months.


Recruitment information / eligibility

Status Terminated
Enrollment 125
Est. completion date
Est. primary completion date September 2012
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

To be considered eligible to participate in this study, subjects must meet the following requirements:

1. Subject has agreed to undergo surgical implantation of the TVT SECUR System

2. Subject has the complaint of SUI for at least 6 months prior to the Preoperative Evaluation Visit.

3. Subject has confirmed SUI resulting from urethral hypermobility on cough stress testing.

4. Subject has at least 4 gm of urine leakage on 1-hour pad testing during the Preoperative Screening Visit.

5. Subject is at least 18 years of age to maximum of 85 years of age

6. Subject is willing and able to give written informed consent prior to any study related procedures.

7. Subject is willing to return for follow-up evaluation and questionnaire completion at 4-6 weeks, and at 3, 6, 12 and 24 month follow-ups.

8. Subject is willing to undergo transvaginal ultrasound evaluation at the 4 weeks and 12 month follow-up visit.

Exclusion Criteria:

Subjects will not be eligible for entry into the study if they meet one of the following criteria:

1. Subject is pregnant.

2. Subject has had any previous synthetic sub-urethral sling procedure.

3. Subject has current urinary tract or vaginal infections.

4. Subject has blood coagulation disorders.

5. Subject has a compromised immune system or any other conditions that would compromise healing.

6. Subject has upper urinary tract obstruction.

7. Subject is unwilling to provide written informed consent.

8. Subject is unwilling or unable to return for evaluation at 4-6 weeks, and at 3, 6, 12, and 24 months.

9. Subject has uncontrolled detrusor overactivity.

10. Subject has PVR greater than 100 cc.

11. Subject has Peak Flow Rate less than 10 ml/sec.

12. Subject has urethral diverticulum.

13. Subject has significant pelvic organ prolapse (Grade III/IV) requiring surgical treatment.

14. Subject has had radiation therapy to the pelvic area at any time.

15. Subject has current or active history of pelvic cancer.

16. Subject who in the opinion of the investigator is unable and/or unlikely to comprehend the nature, scope and possible consequences of the study and to follow the study procedures and instructions and complete all study related measurements.

Study Design

Time Perspective: Prospective


Intervention

Procedure:
Gynecare TVT Secur
Implant of the Gynecare TVT Secur

Locations

Country Name City State
Canada Sunnybrook Health Sciences Centre Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
Sunnybrook Health Sciences Centre Johnson & Johnson

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary endpoints are the cure/improvement rate in the cohort at 12 months. 12 months No
Secondary Distribution of percentage of subjects having a decrease of pad weight as compared to baseline 24 months No
Secondary Decrease in number of pads used within a 24-hour period as compared to baseline 24 months No
Secondary Change in patient questionnaires from baseline 24 months No
Secondary Change in the sling position on transvaginal ultrasound 24 months No
Secondary Cure/improvement rate at 24 months 24 months No
See also
  Status Clinical Trial Phase
Recruiting NCT04829357 - Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
Completed NCT05493735 - Lidocaine for Pessary Check Pain Reduction Phase 3
Completed NCT04512053 - A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence Phase 2
Active, not recruiting NCT06224335 - Measurement of Intravaginal and Intra-abdominal Pressure and Pad Test During Sports Activities (SPORTVAGPRES)
Recruiting NCT05304312 - The Role of Kegel Exercises Book to Improve Treatment in Stress Urinary Incontinence Women N/A
Not yet recruiting NCT05527665 - Sexual Fonction and Discomfort in Women After Midurethral Sling Surgery, Using PPSSQ
Not yet recruiting NCT04558762 - Ten Years Follow-up After Insertion of a MUS (Mid Urethral Sling) Due to Stress Urinary Incontinence
Withdrawn NCT02524366 - A Study of Transcorporal Versus Standard Artificial Urinary Sphincter Placement N/A
Completed NCT01924728 - Efficacy of Magnetic Stimulation for Stress Urinary Incontinence N/A
Completed NCT01676662 - Solace European Confirmatory Trial N/A
Unknown status NCT01455779 - Lyrette: Renewing Continence Objective and Subjective Efficacy Study N/A
Withdrawn NCT00573703 - Laparoscopic Burch Colposuspension Versus Transobturatory Tape for the Treatment of Female Urinary Stress Incontinence Phase 4
Completed NCT01770691 - Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence N/A
Completed NCT01123096 - Is the Cough Stress Test Equivalent to the 24 Hour Pad Test in the Assessment of Stress Incontinence? N/A
Completed NCT00234754 - Trans-Obturator Tape Versus Trans-Vaginal Tape for Stress Urinary Incontinence in Women N/A
Completed NCT00441454 - Retropubic vs. Transobturator Tension-free Vaginal Tape N/A
Completed NCT03985345 - Prospective Evaluation of the Connected EMY Biofeedback Probe in the Management of Stress Urinary Incontinence. N/A
Active, not recruiting NCT03671694 - Laser Vaginal Treatment for SUI N/A
Completed NCT04097288 - Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects Phase 1
Recruiting NCT05272644 - Efficacy of Biofeedback-Assisted Pelvic Muscle Floor Training and Electrical Stimulation on Women With Stress Urinary Incontinence N/A